Brief: ProstaLund's Method Reduces The Risk Of Developing Prostate Cancer
Jan 11 (Reuters) - ProstaLund AB PLUND.ST :
* PROSTALUND'S METHOD REDUCES THE RISK OF DEVELOPING
PROSTATE
CANCER
* PATIENTS TREATED WITH PROSTALUND'S METHOD, CORETHERM, HAVE
MORE
THAN A HALVED RISK OF GETTING A PROSTATE CANCER DIAGNOSIS
Source text for Eikon: ID:nMFN1V1Lxg
Further company coverage: PLUND.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on ProstaLund AB
See all newsBrief: ProstaLund 9M Operating Profit SEK -14 Million
Brief: Prostalund Applies For Delisting From Nasdaq Stockholm
Brief: ProstaLund Takes Out Loan Of SEK 4 Mln From Two Largest Shareholders
Brief: ProstaLund Enters Collaboration Agreement With The XEN Group
Brief: Prostalund Enters Collaboration With Mayumana Healthcare